Zum Inhalt springen

Bulgarian Pharmaceutical Giant Sopharma with Record Profit

1 Min. Lesezeit Quelle: Novinite

Dieser Beitrag ist auf Englisch veröffentlicht.

Aus unserem Nachrichtenarchiv: Dieser Artikel wurde im April 2011 veröffentlicht. Zahlen und Regeln können sich seitdem geändert haben.

Bulgaria's largest pharmaceutical company Sopharma has registered its highest profit in 11 years.

In 2010, Sopharma AD had a profit of BGN 40.5 M, according to newly released company data.

Sopharma's 2010 revenues amounted to BGN 238.5 M, which is a 12% increase year-on-year.

30% of Sopharma's sales in 2010 were on Bulgaria's domestic market but the major factor for its revenue growth was its export to foreign markets which grew 19% compared with 2009.

Sopharma's 2010 gross expenditures amounted to BGN 193 M, an increase of 10% year-on-year.

Sopharma's own capital is BGN 296 M, which is a 16.6% increase in 2010 year-on-year.

In 2010, the pharmaceutical company's export to Russia increased by 20%, and to Ukraine – by 28%.

Ursprünglich veröffentlicht von Novinite.